Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

Eli Lilly is broadening its direct-to-consumer approach by partnering with a digital health company, Noom, which is focused ...

Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced an agreement ...

Montreal, Quebec, Canada, March 31, 2025 (GLOBE NEWSWIRE) -- In recognition of World Cloud Security Day on April 3rd, Genetec Inc. ("Genetec”), the global leader in enterprise physical security ...

According to reports, Boutherin expressed concern in a new research note that the subscriptions for Wegovy are trailing those of its great rival, Zepbound, from American pharmaceutical titan Eli ...

Collective Health and Noom’s joint offering delivers cost savings ... including home delivery of brand-name medications like Wegovy® and Zepbound®, ensuring members receive timely treatment.

Eli Lilly has benefitted from the windfall from tirzepatide – the active ingredient in its weight loss injection Zepbound and diabetes shot Mounjaro – which targets GLP-1 but also activates ...

This is a dual GLP-1 and GIP receptor agonist similar to Lilly's Zepbound. In a phase 2 trial, patients receiving VK2735 lost an average of 13.1% of their weight compared to those taking a placebo ...

The days of cheaper alternatives to popular weight-loss drugs like Wegovy and Zepbound are over for some Long Islanders and are numbered for others, pharmacists and compounding industry groups say.